This inventor holds 2 USPTO granted patents. Top assignees: Bristol-Myers Squibb Compnay, Kosan Biosciences Incorporated. Active years: 2008-2010.
Company Filing History:
1 out of 3,736 
1 out of 110 Years Active: 2008-2010
Title: The Innovations of Timothy Leaf
Introduction
Timothy Leaf is an accomplished inventor based in Newark, CA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on innovative methods and formulations that enhance the efficacy of therapeutic compounds.
Latest Patents
Timothy Leaf's latest patents include "17-allylamino-17-demethoxygeldanamycin polymorphs and formulations" and "Method of producing a compound by fermentation." The first patent addresses polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxygeldanamycin (17-AAG), which is crucial for cancer treatment. The second patent outlines a method for producing a compound through fermentation, where the concentration of a precursor compound is maintained within a pre-selected range using an adsorbent resin. This innovative approach allows for the efficient production of desired compounds while controlling precursor levels.
Career Highlights
Throughout his career, Timothy Leaf has worked with notable companies such as Bristol-Myers Squibb Company and Kosan Biosciences Incorporated. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.
Collaborations
Timothy has collaborated with several professionals in his field, including Peter J Licari and Ruchir Desai. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Timothy Leaf's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a significant inventor. His innovative approaches continue to influence the development of effective therapeutic solutions.